9Suppliers
30Customers
2Debt Items
20Related Chains

Harvard Bioscience, Inc. Suppliers

TickerNameConfidenceEvidence
CITIZENS-BANK-N-A CITIZENS-BANK-N-A 92% The proceeds of the Term Loans will be used to repay all obligations under the Company’s prior credit facility for which Citizens Bank, N.A. served as administrative agent
BROADOAK-INCOME-FUND-L-P BROADOAK-INCOME-FUND-L-P 90% the Loan and Security Agreement with certain financial institutions party thereto as lenders (the “Lenders”) and BroadOak, L.P. (“BroadOak”), as the administrative agent and collateral agent
BDX Becton, Dickinson and Company 72% nt activities to advance our position in the industry as a provider of life science equipment, software and services. We plan to pursue a balanced development portfolio strategy of originating new pr…
BDX Becton, Dickinson and Company 72% Reciprocal relationship from BDX graph: Reciprocal relationship from HBIO graph: nt activities to advance our position in the industry as a provider of life science equipment, software and services. …
BIO Bio-Rad Laboratories, Inc. 72% nt activities to advance our position in the industry as a provider of life science equipment, software and services. We plan to pursue a balanced development portfolio strategy of originating new pr…
BIO Bio-Rad Laboratories, Inc. 72% Reciprocal relationship from BIO graph: Reciprocal relationship from HBIO graph: Reciprocal relationship from BIO graph: Reciprocal relationship from HBIO graph: nt activities to advance our position…
JNJ Johnson & Johnson 72% . Army and CROs. Our pharmaceutical and biotechnology customers include pharmaceutical companies and research laboratories such as Abbott, Amgen, AstraZeneca, Bayer, Glaxo Smith Kline, Johnson & John…
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from HBIO graph: . Army and CROs. Our pharmaceutical and biotechnology customers include pharmaceutical companies and research laborato…
MXCT MaxCyte, Inc. 72% Reciprocal relationship from MXCT graph: Reciprocal relationship from HBIO graph: Reciprocal relationship from MXCT graph: Reciprocal relationship from HBIO graph: Reciprocal relationship from MXCT g…

Harvard Bioscience, Inc. Customers

TickerNameConfidenceEvidence
USGOV-DEPARTMENT-OF-AGRICULTURE USGOV-DEPARTMENT-OF-AGRICULTURE 95% USAspending awards from Department of Agriculture: $108,983 across 1 awards. 1232SA25P0198 AMINO ACID ANALYZER WITH COLUMN, PC AND DATA ANALYSIS SOFTWARE, PHYSIOLOGICAL STANDARD, BUFFER START-UP KIT,…
ABBOTT ABBOTT 92% Our pharmaceutical and biotechnology customers include companies and research laboratories such as Abbott, Amgen, AstraZeneca, Bayer, Glaxo Smith Kline, Johnson & Johnson, Merck, Novartis, Pfizer and…
AMGN Amgen Inc. 92% Reciprocal relationship from AMGN graph: Reciprocal relationship from HBIO graph: Our pharmaceutical and biotechnology customers include companies and research laboratories such as Abbott, Amgen, Ast…
AMGN Amgen Inc. 92% Our pharmaceutical and biotechnology customers include companies and research laboratories such as Abbott, Amgen, AstraZeneca, Bayer, Glaxo Smith Kline, Johnson & Johnson, Merck, Novartis, Pfizer and…
AZN AstraZeneca PLC 92% Reciprocal relationship from AZN graph: Reciprocal relationship from HBIO graph: Reciprocal relationship from AZN graph: Reciprocal relationship from HBIO graph: Our pharmaceutical and biotechnology …
AZN AstraZeneca PLC 92% Our pharmaceutical and biotechnology customers include companies and research laboratories such as Abbott, Amgen, AstraZeneca, Bayer, Glaxo Smith Kline, Johnson & Johnson, Merck, Novartis, Pfizer and…
BAYER BAYER 92% Our pharmaceutical and biotechnology customers include companies and research laboratories such as Abbott, Amgen, AstraZeneca, Bayer, Glaxo Smith Kline, Johnson & Johnson, Merck, Novartis, Pfizer and…
BAYLOR-COLLEGE-OF-MEDICINE BAYLOR-COLLEGE-OF-MEDICINE 92% Our academic customers include colleges and universities such as Baylor College of Medicine, Cambridge University, Harvard University, Imperial College of London, Johns Hopkins University, Stanford, …
CAMBRIDGE-UNIVERSITY CAMBRIDGE-UNIVERSITY 92% Our academic customers include colleges and universities such as Baylor College of Medicine, Cambridge University, Harvard University, Imperial College of London, Johns Hopkins University, Stanford, …
CHARLES-RIVER-LABORATORIES CHARLES-RIVER-LABORATORIES 92% Our CRO customers include Charles River Laboratories, Labcorp and Wuxi AppTec.
GLAXO-SMITH-KLINE GLAXO-SMITH-KLINE 92% Our pharmaceutical and biotechnology customers include companies and research laboratories such as Abbott, Amgen, AstraZeneca, Bayer, Glaxo Smith Kline, Johnson & Johnson, Merck, Novartis, Pfizer and…
HARVARD-UNIVERSITY HARVARD-UNIVERSITY 92% Our academic customers include colleges and universities such as Baylor College of Medicine, Cambridge University, Harvard University, Imperial College of London, Johns Hopkins University, Stanford, …
IMPERIAL-COLLEGE-OF-LONDON IMPERIAL-COLLEGE-OF-LONDON 92% Our academic customers include colleges and universities such as Baylor College of Medicine, Cambridge University, Harvard University, Imperial College of London, Johns Hopkins University, Stanford, …
JOHNS-HOPKINS-UNIVERSITY JOHNS-HOPKINS-UNIVERSITY 92% Our academic customers include colleges and universities such as Baylor College of Medicine, Cambridge University, Harvard University, Imperial College of London, Johns Hopkins University, Stanford, …
LABCORP LABCORP 92% Our CRO customers include Charles River Laboratories, Labcorp and Wuxi AppTec.
MRK Merck & Co., Inc. 92% Reciprocal relationship from MRK graph: Reciprocal relationship from HBIO graph: Reciprocal relationship from MRK graph: Reciprocal relationship from HBIO graph: Our pharmaceutical and biotechnology …
MRK Merck & Co., Inc. 92% Our pharmaceutical and biotechnology customers include companies and research laboratories such as Abbott, Amgen, AstraZeneca, Bayer, Glaxo Smith Kline, Johnson & Johnson, Merck, Novartis, Pfizer and…
NVS Novartis AG 92% Our pharmaceutical and biotechnology customers include companies and research laboratories such as Abbott, Amgen, AstraZeneca, Bayer, Glaxo Smith Kline, Johnson & Johnson, Merck, Novartis, Pfizer and…
NVS Novartis AG 92% Reciprocal relationship from NVS graph: Reciprocal relationship from HBIO graph: Our pharmaceutical and biotechnology customers include companies and research laboratories such as Abbott, Amgen, Astr…
PFE Pfizer Inc. 92% Reciprocal relationship from PFE graph: Reciprocal relationship from HBIO graph: Reciprocal relationship from PFE graph: Reciprocal relationship from HBIO graph: Our pharmaceutical and biotechnology …
PFE Pfizer Inc. 92% Our pharmaceutical and biotechnology customers include companies and research laboratories such as Abbott, Amgen, AstraZeneca, Bayer, Glaxo Smith Kline, Johnson & Johnson, Merck, Novartis, Pfizer and…
REGENERON REGENERON 92% Our pharmaceutical and biotechnology customers include companies and research laboratories such as Abbott, Amgen, AstraZeneca, Bayer, Glaxo Smith Kline, Johnson & Johnson, Merck, Novartis, Pfizer and…
STANFORD STANFORD 92% Our academic customers include colleges and universities such as Baylor College of Medicine, Cambridge University, Harvard University, Imperial College of London, Johns Hopkins University, Stanford, …
UNITED-STATES-NATIONAL-INSTITUTES-OF-HEALTH UNITED-STATES-NATIONAL-INSTITUTES-OF-HEALTH 92% Our end-user customers are primarily pharmaceutical and biotechnology companies, universities, hospitals, government laboratories, including laboratories operated by the United States National Instit…
UNIVERSITY-OF-CALIFORNIA-SYSTEM UNIVERSITY-OF-CALIFORNIA-SYSTEM 92% Our academic customers include colleges and universities such as Baylor College of Medicine, Cambridge University, Harvard University, Imperial College of London, Johns Hopkins University, Stanford, …
UNIVERSITY-OF-PENNSYLVANIA UNIVERSITY-OF-PENNSYLVANIA 92% Our academic customers include colleges and universities such as Baylor College of Medicine, Cambridge University, Harvard University, Imperial College of London, Johns Hopkins University, Stanford, …
UNIVERSITY-OF-PITTSBURGH UNIVERSITY-OF-PITTSBURGH 92% Our academic customers include colleges and universities such as Baylor College of Medicine, Cambridge University, Harvard University, Imperial College of London, Johns Hopkins University, Stanford, …
UNIVERSITY-OF-TEXAS UNIVERSITY-OF-TEXAS 92% Our academic customers include colleges and universities such as Baylor College of Medicine, Cambridge University, Harvard University, Imperial College of London, Johns Hopkins University, Stanford, …
WUXI-APPTEC WUXI-APPTEC 92% Our CRO customers include Charles River Laboratories, Labcorp and Wuxi AppTec.
YALE-UNIVERSITY YALE-UNIVERSITY 92% Our academic customers include colleges and universities such as Baylor College of Medicine, Cambridge University, Harvard University, Imperial College of London, Johns Hopkins University, Stanford, …

Harvard Bioscience, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
HBIO-DEBT Debt stack $44.3M 90% Market cache reports total debt of $44.3M.
HBIO-DEBT-15505 Warrants outstanding: 1342000 90% xbrl warrant detail from xbrl 2025-12-31.

Harvard Bioscience, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Harvard Bioscience, Inc..

Harvard Bioscience, Inc. Ownership

HolderNameConfidenceEvidence
HBIO-OWNER-BARCLAYS-PLC BARCLAYS PLC 90% 13F overlay lists BARCLAYS PLC as top holder; 8 tracked holders.

Harvard Bioscience, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CSTE Caesarstone Ltd. 100.00 2
CHRS Coherus Oncology, Inc. 100.00 2
CCCC C4 Therapeutics, Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
EDSA Edesa Biotech, Inc. 100.00 2
BLLN BillionToOne, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
IMMP Immutep Limited 100.00 2
DTIL Precision BioSciences, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
AORT Artivion, Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
CRBP Corbus Pharmaceuticals Holdings, Inc. 100.00 2
DEO Diageo plc 100.00 2
BNBX BNB Plus Corp. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
BNR Burning Rock Biotech Limited 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
DYN Dyne Therapeutics, Inc. 100.00 2